ProstaCaid™ inhibits tumor growth in a xenograft model of human prostate cancer

By            

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1339-1344

Spandidos Publications

Access to resources Recommend Favorite

MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer

By Cozzi Paul   Wang Jian   Delprado Warick   Perkins Alan   Allen Barry   Russell Pamela   Li Yong  

Clinical and Experimental Metastasis, Vol. 22, Iss. 7, 2005-11 ,pp. : 565-573

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model

By              

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 933-938

Spandidos Publications

Access to resources Recommend Favorite

Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo

By Ghadersohi Ali   Pan Dalin   Fayazi Zahra   Hicks David   Winston Janet   Li Fengzhi  

Breast Cancer Research and Treatment, Vol. 102, Iss. 1, 2007-03 ,pp. : 19-30

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment

By              

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1113-1121

Spandidos Publications

Access to resources Recommend Favorite